<DOC>
	<DOCNO>NCT01685073</DOCNO>
	<brief_summary>The number people seek treatment marijuana-related problem rise , yet currently accept medication proven help quit . Frequent marijuana user report trouble sleep try quit , loss sleep lead relapse . This research design measure severity sleep problem people try quit heavy use marijuana , investigate whether extended-release zolpidem ( Ambien CRÂ® ) improve quit rate among people try stop use marijuana .</brief_summary>
	<brief_title>The Role Sleep Treatment Cannabis Use Disorders</brief_title>
	<detailed_description />
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>1 . Age 1855 year . 2 . Recent problematic use cannabis 3 . Cannabis use impact sleep 1 . Dependent drug cannabis nicotine , current Axis I psychiatric disorder 2 . Moderate sleep apnea periodic limb movement disorder 3 . Pregnant , breast feeding , plan become pregnant within next 3 month 4 . Current condition associate severe cognitive/social impairment 5 . Allergy ingredient extendedrelease zolpidem prior adverse reaction zolpidem 6 . Current use drug affect metabolism via cytochrome P450 current illness result severe hepatic impairment 7 . Current use hypnotic medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>marijuana</keyword>
	<keyword>cannabis</keyword>
	<keyword>treatment</keyword>
	<keyword>insomnia</keyword>
	<keyword>relapse</keyword>
</DOC>